Asian Spectator

.
Business Advice

.

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SYDNEY, June 1, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Sulitnya televisi lokal bermigrasi digital, bagaimana solusinya?

Dunia penyiaran kita masih menyimpan persoalan kompleks yang belum ada jalan keluarnya. Amanah Undang-Undang (UU) No. 32 Tahun 2002 tentang Penyiaran yang memiliki semangat desentralisasi kepemilikan ...

Bukan lagi ‘shadow war’: rivalitas Israel-Iran kini menjadi perang nyata–adakah jalan untuk kembali?

Sistem pertahanan udara Israel mencegat hampir semua rudal yang ditembakkan dari Iran pada 13 April 2024.AP Photo/Tomer NeubergSelama beberapa dekade, Iran dan Israel telah terlibat dalam ‘shado...

The Top 10 Reasons to Purchase Bedroom Curtains

Curtains are more than just fabric hanging by your windows; they play a crucial role in the comfort, functionality, and aesthetic of your bedroom. Here are the top ten reasons why purchasing bedroom...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion